Bacterial translocation across ePTFE vascular graft surfaces

Journal of Infection

Volumn 60, Issue 6, 2010, Pages 486-490

  Narasimhan, Supriya ^a,b   Aslam, Saima ^a,b   Lin, Peter H ^a,b   Bechara, Carlos F ^a,b   Mansouri, Mohammad D ^a   Darouiche, Rabih O ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

EPTFE grafts; Escherichia coli; Staphylococcus aureus; Translocation

Indexed keywords

METICILLIN; POLITEF;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; GRAFT INFECTION; IN VITRO STUDY; INCUBATION TIME; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOGENESIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SUSPENSION; TIME; VALIDATION STUDY;

BACTERIAL TRANSLOCATION; BLOOD VESSEL PROSTHESIS; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POLYTETRAFLUOROETHYLENE;

EID: 77953321318     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.03.023     Document Type: Article

References (14)

1. Rowe V.L., Lee W., Weaver F.A., Etzioni D. Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg 2009, 49(4):910-917.
2. Wilson S.E. New alternatives in management of the infected vascular prosthesis. Surg Infect 2001, 2(2):171-175.
3. Xue L., Griesler H.P. Biomaterials in the development and future of vascular grafts. J Vasc Surg 2003, 37(2):472-480.
4. Hazama K., Miura H., Shimada T., Okada Y., Murashita T., Nishibe T. Relationship between fibril length and tissue ingrowth in the healing of expanded polytetrafluoroethylene grafts. Surg Today 2004, 34:685-689.
5. Aslam S., Trautner B.W., Ramanathan V., Darouiche R.O. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother 2007, 51(4):1556-1558.
6. Schmacht D., Armstrong P., Johnson B., Pierre K., Back M., Honeyman A., et al. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination. Vasc Endovascular Surg 2005, 39(5):411-420.
7. Kaebnick H.W., Bandyk D.F., Bergamini T.W., Towne J.B. The microbiology of explanted vascular prostheses. Surgery 1987, 102(4):756-762.
8. Chambers S.T. Diagnosis and management of staphylococcal infections of vascular grafts and stents. Intern Med J 2005, 35:S72-S78.
9. Quinones-Baldrich W.J., Hernandez J.J., Moore W.S. Long-term results following surgical management of aortic graft infection. Arch Surg 1991, 126:507-511.
10. Bunt T.J. Vascular graft infections: an update. Cardiovasc Surg 2001, 9:225-233.
11. Raad I. Intravascular-catheter-related infections. Lancet 1998, 351:893-898.
12. Campbell C.D., Goldfarb D., Roe R. A small arterial substitute: expanded polytetrafluoroethylene: patency versus porosity. Ann Surg 1975, 182(2):138-143.
13. Mathiasen S.R., Wu H.D., Sauvage L.R., Usui Y., Walker M.W. An experimental study of eight current arterial prosthesis. J Vasc Surg 1986, 4:33-41.
14. Darouiche R.O., Raad, Heard S.O., Thornby J.I., Wenker O.C., Gabrielli A., et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999, 340(1):1-8.